These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26434431)

  • 1. Invited Commentary.
    Akhter SA
    Ann Thorac Surg; 2015 Oct; 100(4):1297. PubMed ID: 26434431
    [No Abstract]   [Full Text] [Related]  

  • 2. Driveline infection after HeartMate II associated with lower rates of cardiac transplantation and increased incidence of sepsis in bridge-to-transplant population.
    Harvey L; Holley C; Cogswell R; Eckman P; Colvin-Adams M; Liao K; John R
    Minn Med; 2014 May; 97(5):40. PubMed ID: 24941589
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heart transplantation and assist devices].
    Görler H; Haverich A
    Herz; 2004 Nov; 29(7):695-701. PubMed ID: 15580324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited commentary.
    Esmore DS
    Ann Thorac Surg; 2010 Oct; 90(4):1277. PubMed ID: 20868827
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of Heart Transplant After Left Ventricular Assist Device Specific and Related Infection.
    Tong MZ; Smedira NG; Soltesz EG; Starling RC; Koval CE; Porepa L; Moazami N
    Ann Thorac Surg; 2015 Oct; 100(4):1292-7. PubMed ID: 26188972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited commentary.
    Yuh DD
    Ann Thorac Surg; 2012 Nov; 94(5):1386. PubMed ID: 23098928
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation.
    Bhatia N; Voelkel AJ; Hussain Z; Sharma UC; Slaughter MS; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):675-83. PubMed ID: 26366889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massive occult infection of a left ventricular assist device with Candida albicans.
    Sabashnikov A; Mohite PN; Zych B; Popov AF; Garcia D; Simon AR
    Artif Organs; 2013 Jun; 37(6):582-3. PubMed ID: 23638703
    [No Abstract]   [Full Text] [Related]  

  • 9. Invited commentary.
    Hendry P
    Ann Thorac Surg; 2007 Aug; 84(2):520-1. PubMed ID: 17643628
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
    Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
    Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients.
    Marian U; Slavcev A; Gazdic T; Ivak P; Netuka I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):518-523. PubMed ID: 27132810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of F-18 FDG PET-CT for the diagnosis and management of infection in JARVIK 2000 device.
    Costo S; Hourna E; Massetti M; Belin A; Bouvard G; Agostini D
    Clin Nucl Med; 2011 Dec; 36(12):e188-91. PubMed ID: 22064105
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of left ventricular assist device infection on post-transplant outcomes.
    Schulman AR; Martens TP; Russo MJ; Christos PJ; Gordon RJ; Lowy FD; Oz MC; Naka Y
    J Heart Lung Transplant; 2009 Mar; 28(3):237-42. PubMed ID: 19285614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist device-related infection: treatment and outcome.
    Simon D; Fischer S; Grossman A; Downer C; Hota B; Heroux A; Trenholme G
    Clin Infect Dis; 2005 Apr; 40(8):1108-15. PubMed ID: 15791509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to remove the retroauricular driveline in the Jarvik 2000 after heart transplantation.
    Gallo M; Bortolussi G; Bejko J; Tarzia V; Gerosa G; Bottio T
    Int J Artif Organs; 2016 Jan; 39(1):45-7. PubMed ID: 26868215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Status 1A Heart Transplantation Survival in the Continuous Flow Left Ventricular Assist Device Era.
    Trivedi JR; Rajagopal K; Schumer EM; Birks EJ; Lenneman A; Cheng A; Slaughter MS
    Ann Thorac Surg; 2016 Nov; 102(5):1512-1516. PubMed ID: 27329191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of mechanical circulatory support on post-transplant survival a different view.
    Miller L
    J Am Coll Cardiol; 2009 Jan; 53(3):272-4. PubMed ID: 19147044
    [No Abstract]   [Full Text] [Related]  

  • 18. Infections associated with implanted blood pumps.
    Burns GL
    Int J Artif Organs; 1993 Nov; 16(11):771-6. PubMed ID: 8150523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HeartMate-II left ventricular assist device infections resulting from gastrointestinal-tract fistulas.
    Akay MH; Gregoric I; Cohn WE; Frazier OH
    J Card Surg; 2012 Sep; 27(5):643-5. PubMed ID: 22978845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.